Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Sales | 589 | 646 | 560 | 428 | 41 |
| Operating Expenses | 776 | 809 | 591 | 847 | 847 |
| Operating Income | -186 | -163 | -30 | -419 | -806 |
| Interest Expense | 41 | 44 | 15 | 55 | 36 |
| Other Income | 6 | -1 | -223 | -13 | 50 |
| Pre-tax Income | -222 | -208 | -269 | -487 | -793 |
| Net Income Continuous | -222 | -208 | -269 | -487 | -793 |
| Net Income | $-222 | $-208 | $-269 | $-487 | $-793 |
| EBITDA(a) | $-99 | $-80 | $-166 | $-359 | $-687 |